Oruka Therapeutics (ORKA) Stock Insights

ORKA price $94.54 -1.27 -1.32%

Ticker
ORKA
Price
$94.54
Change
-1.27 -1.32%
Market cap ?
$6.26B
P/E ?
-36.20
Dividend yield ?
0.00%
Beta ?
-0.39
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
52
Quality
48
Growth
91

Stocklytics score rationale: value 52, quality 48, growth 91.

Financials

2016201720182019202020212022202320242025
0000000000

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in…

Fair value

ORKA fair value Not meaningful. Price $94.54.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ORKA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.60——
2026-08-10-0.55-0.51——
2026-05-13-0.48-0.55——
2026-03-12-0.45-0.61——
2025-11-12-0.55-0.56——
2025-08-11-0.46-0.48——
2025-05-14-0.40-0.57——
2025-03-06-0.49-0.68——
2024-11-13-1.46-0.40——
2024-08-01-0.76———
2024-04-25-0.14———
2023-12-31-0.08———
2023-09-30-0.10———
2023-06-30-0.10———
2023-03-31-0.09———
2022-12-31-0.98———
2022-09-30-1.94———
2022-06-30-2.62———
2022-03-31-2.72———
2021-12-31-4.73-26.88——
2021-09-30-3.92-27.60——
2021-06-30-4.03-28.44——
2021-03-31-3.98-22.44——
2020-12-31-6.44-29.28——
2020-09-30-3.95———
2020-06-30-8.71———
2020-03-31-9.94———
2019-12-31-9.23———
2019-09-30-9.12———
2019-06-30-13.64———
2019-03-31-22.29———
2018-12-31-23.10———
2018-09-30-24.71———
2018-06-30-32.83———
2018-03-31-43.37———
2017-12-31-76.99———
2017-09-30-83.24———
2017-06-30-127.91———
2017-03-31-103.03———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Special.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2024-08-29$19.362024-08-26—Special

Insider trades

DateInsiderActionSharesPriceValue
2026-10-20Quinlan Paul TSell9.00K$7.8070.20K
2026-10-20Quinlan Paul TBuy9.00K$7.8070.20K
2026-10-20Quinlan Paul TSell400$74.9029.96K
2026-10-20Quinlan Paul TSell500$76.1238.06K
2026-10-20Quinlan Paul TSell1.00K$77.2077.20K
2026-10-20Quinlan Paul TSell4.10K$78.79323.04K
2026-10-20Quinlan Paul TSell3.00K$79.49238.47K
2026-10-15Goncalves JoanaSell3.50K$6.8423.94K
2026-10-15Goncalves JoanaSell3.50K$7.8027.30K
2026-10-15Goncalves JoanaBuy3.50K$7.8027.30K
2026-10-15Goncalves JoanaSell2.85K$73.89210.81K
2026-10-15Goncalves JoanaBuy3.50K$6.8423.94K
2026-10-15Goncalves JoanaSell1.85K$74.69137.96K
2026-10-15Goncalves JoanaSell1.40K$75.48105.68K
2026-10-15Goncalves JoanaSell700$76.6753.67K
2026-10-15Goncalves JoanaSell200$77.7115.54K
2026-10-12Agarwal ArjunSell8.54K$12.50106.76K
2026-10-12Agarwal ArjunSell1.46K$34.3950.14K
2026-10-12Agarwal ArjunBuy1.46K$34.3950.14K
2026-10-12Agarwal ArjunBuy8.54K$12.50106.76K
2026-10-12Agarwal ArjunSell5.74K$80.03459.45K
2026-10-12Agarwal ArjunSell2.10K$80.76169.60K
2026-10-12Agarwal ArjunSell1.96K$81.86160.27K
2026-10-12Agarwal ArjunSell200$82.8316.57K
2026-10-01Klein Lawrence OttoSell25.00K$7.80195.00K
2026-10-01Klein Lawrence OttoBuy25.00K$7.80195.00K
2026-10-01Klein Lawrence OttoSell16.25K$83.401.35M
2026-10-01Klein Lawrence OttoSell8.55K$84.03718.75K
2026-10-01Klein Lawrence OttoSell200$84.7816.96K
2026-09-21Agarwal ArjunSell533$95.7551.03K
2026-09-21Quinlan Paul TSell10.00K$7.8078.00K
2026-09-21Quinlan Paul TBuy10.00K$7.8078.00K
2026-09-21Quinlan Paul TSell2.90K$92.37267.87K
2026-09-21Quinlan Paul TSell3.83K$93.32357.59K
2026-09-21Quinlan Paul TSell601$94.4456.76K
2026-09-21Quinlan Paul TSell2.67K$95.31254.20K
2026-09-15Goncalves JoanaSell3.50K$6.8423.94K
2026-09-15Goncalves JoanaSell3.50K$7.8027.30K
2026-09-15Goncalves JoanaBuy3.50K$7.8027.30K
2026-09-15Goncalves JoanaSell2.38K$91.10217.17K
2026-09-15Goncalves JoanaBuy3.50K$6.8423.94K
2026-09-15Goncalves JoanaSell3.15K$92.03289.89K
2026-09-15Goncalves JoanaSell1.37K$92.99127.02K
2026-09-15Goncalves JoanaSell100$94.229.42K
2026-09-15Goncalves JoanaSell947$95.7190.64K
2026-09-15Agarwal ArjunSell560$95.7153.60K
2026-09-15Klein Lawrence OttoSell2.45K$95.71234.68K
2026-09-15Quinlan Paul TSell1.04K$95.7199.44K
2026-09-15Sandler Laura LeeSell906$95.7186.71K
2026-09-11Agarwal ArjunSell8.00K$12.50100.00K
2026-09-11Agarwal ArjunSell1.46K$34.3950.18K
2026-09-11Agarwal ArjunBuy1.46K$34.3950.18K
2026-09-11Agarwal ArjunBuy8.00K$12.50100.00K
2026-09-11Agarwal ArjunSell3.00K$91.11273.32K
2026-09-11Agarwal ArjunSell4.05K$92.41374.37K
2026-09-11Agarwal ArjunSell2.21K$93.26205.92K
2026-09-11Agarwal ArjunSell200$94.0218.80K
2026-09-01Sandler Laura LeeBuy5.00K$7.8039.00K
2026-09-01Sandler Laura LeeSell1.00K$91.0591.05K
2026-09-01Sandler Laura LeeSell4.00K$92.01368.05K
2026-09-01Sandler Laura LeeSell5.00K$7.8039.00K
2026-09-01Klein Lawrence OttoSell75.00K$7.80585.00K
2026-09-01Klein Lawrence OttoBuy75.00K$7.80585.00K
2026-09-01Klein Lawrence OttoSell6.60K$90.79599.56K
2026-09-01Klein Lawrence OttoSell63.60K$91.905.84M
2026-09-01Klein Lawrence OttoSell4.80K$92.44443.69K
2026-08-24Edwards Larry ToddBuy100.00K——
2026-08-24Edwards Larry ToddBuy20.00K$102.422.05M
2026-08-24Edwards Larry ToddOther0——
2026-08-17Goncalves JoanaSell3.50K$6.8423.94K
2026-08-17Goncalves JoanaSell3.50K$7.8027.30K
2026-08-17Goncalves JoanaBuy3.50K$7.8027.30K
2026-08-17Goncalves JoanaSell900$109.6598.69K
2026-08-17Goncalves JoanaSell300$110.5233.16K
2026-08-17Goncalves JoanaBuy3.50K$6.8423.94K
2026-08-17Goncalves JoanaSell3.32K$112.01371.89K
2026-08-17Goncalves JoanaSell2.48K$112.56279.15K
2026-08-14Quinlan Paul TSell42.00K$12.50525.00K
2026-08-14Quinlan Paul TSell10.00K$7.8078.00K
2026-08-14Quinlan Paul TBuy42.00K$12.50525.00K
2026-08-14Quinlan Paul TSell3.63K$106.05384.96K
2026-08-14Quinlan Paul TSell10.43K$107.141.12M
2026-08-14Quinlan Paul TSell14.70K$107.971.59M
2026-08-14Quinlan Paul TSell10.20K$109.111.11M
2026-08-14Quinlan Paul TBuy10.00K$7.8078.00K
2026-08-14Quinlan Paul TSell9.19K$110.001.01M
2026-08-14Quinlan Paul TSell3.85K$111.14427.55K
2026-08-13Agarwal ArjunSell8.54K$12.50106.78K
2026-08-13Agarwal ArjunSell1.46K$34.3950.14K
2026-08-13Agarwal ArjunBuy1.46K$34.3950.14K
2026-08-13Agarwal ArjunBuy8.54K$12.50106.78K
2026-08-13Agarwal ArjunSell2.10K$104.67219.81K
2026-08-13Agarwal ArjunSell2.13K$105.57225.08K
2026-08-13Agarwal ArjunSell1.27K$106.63135.20K
2026-08-13Agarwal ArjunSell2.14K$107.71230.72K
2026-08-13Agarwal ArjunSell2.36K$108.46255.76K
2026-07-15Goncalves JoanaSell3.50K$6.8423.94K
2026-07-15Goncalves JoanaSell3.50K$7.8027.30K
2026-07-15Goncalves JoanaBuy3.50K$7.8027.30K
2026-07-15Goncalves JoanaSell400$84.3633.75K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 266, holders +79 vs prior quarter. Ownership 118.61%.

HolderSharesChangeChange %Value
FMR LLC9.06M1.63M+21.88%862.02M
BLACKROCK, INC.4.99M1.46M+41.48%474.92M
VENROCK ADVISER, LLC4.15M00.00%394.81M
FAIRMOUNT FUNDS MANAGEMENT LLC3.71M00.00%352.63M
CAPITAL WORLD INVESTORS3.40M3.40MNew323.73M
RTW INVESTMENTS, LP3.14M1.08M+52.52%298.74M
STATE STREET CORP2.67M1.06M+65.67%254.38M
VANGUARD CAPITAL MANAGEMENT LLC2.36M501.34K+26.96%224.69M
PARADIGM BIOCAPITAL ADVISORS LP2.14M-175.79K-7.58%204.09M
DEEP TRACK CAPITAL, LP1.93M-108.20K-5.32%183.30M
BELLEVUE GROUP AG1.66M1.15M+226.86%157.71M
FRANKLIN TEMPLETON INC1.62M617.39K+61.49%154.31M
REMEDIUM CAPITAL PARTNERS, LLC1.57M00.00%149.00M
RA CAPITAL MANAGEMENT, L.P.1.55M1.55MNew147.95M
VIKING GLOBAL INVESTORS LP1.50M-1.16M-43.62%143.09M
GEODE CAPITAL MANAGEMENT, LLC1.43M475.09K+49.75%136.11M
JUPITER TOPCO LLC1.38M1.38MNew130.97M
PERCEPTIVE ADVISORS LLC1.35M-50.44K-3.61%128.01M
POLAR CAPITAL HOLDINGS PLC1.23M180.92K+17.27%116.93M
CITADEL ADVISORS LLC1.12M111.47K+11.06%106.50M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.1.10M1.10MNew105.04M
BNP PARIBAS FINANCIAL MARKETS1.08M1.08MNew102.69M
PRICE T ROWE ASSOCIATES INC /MD/838.60K111.15K+15.28%79.81M
AVIDITY PARTNERS MANAGEMENT LP760.42K00.00%72.37M
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC658.30K658.30KNew62.65M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Oruka Therapeutics (ORKA) Stock Insights

ORKA$94.54-1.27 -1.32%

$6.26B

Market Cap

-36.20

P/E

—

Forward P/E

64

Score

Price History